Journal
ANTIVIRAL RESEARCH
Volume 172, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.antiviral.2019.104619
Keywords
Histone deacetylase; Hepatitis B virus; HBV cccDNA; Epigenetic modification
Categories
Funding
- National Nature Science Foundation of China [31621061, 31770180]
- National Key Research and Development Program of China [2018YFA0507200]
- Youth planning project of Hubei Health Planning Commission [WJ2017Q027]
- Youth Innovation Promotion Association CAS [2016303]
Ask authors/readers for more resources
Hepatitis B virus (HBV) infection remains an important public health problem worldwide. Covalently closed circular DNA (cccDNA) exhibits as an individual minichromosome and is the molecular basis of HBV infection persistence and antiviral treatment failure. In the current study, we demonstrated that histone deacetylase 11 (HDAC11) inhibits HBV transcription and replication in HBV-transfected Huh7 cells. By using an HBV in vitro infection system, HDAC11 was found to affect the transcriptional activity of cccDNA but did not affect cccDNA production. Chromatin immunoprecipitation (ChIP) assays were utilized to analyze the epigenetic modifications of cccDNA. The results show that HDAC11 specifically reduced the acetylation level of cccDNA-bound histone H3 but did not affect that of histone H4. Furthermore, HDAC11 overexpression decreased the levels of cccDNA-bound acetylated H3K9 (H3K9ac) and H3K27 (H3K27ac). In conclusion, HDAC11 restricts HBV replication through epigenetic repression of cccDNA transcription. These findings reveal the novel role of HDAC11 in HBV infection, further broadening our knowledge regarding the functions of HDAC11 and the roles of HDACs in the epigenetic regulation of HBV cccDNA.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available